Vascularsurgeryprintreadyannualreport17
-
Upload
umhs-pr-marketing-communicat -
Category
Documents
-
view
214 -
download
2
description
Transcript of Vascularsurgeryprintreadyannualreport17
Vascular Surgery 2 0 1 2 A N N U A L R E P O R T
Vascular Surgery
Services
2
Surgical Indicators 2
Diagnostic Venous
Unit
3
Meet Our Support
Staff
3
Multidisciplinary
Aortic Program
4
Pediatric Vascular
Disease Program
4
Peripheral Arterial
Disease Program
5
Venous Health
Program
5
Cardiovascular
Center
6
Livonia Vein Clinic 6
Veterans
Administration
6
Residency and
Fellowship
Programs
7
Students 7
Other Programs 7
Vascular Surgery
Research
8
Clinical Trials 9
Quality Assurance 9
Faculty Updates 10
Development 12
Your Support Makes
a Difference
Acknowledging our
Supporters
12
12
12
Success for Today… Vision for Tomorrow
In This Issue
Vascular Surgery at the University of
Michigan Health System (UMHS) has
realized significant achievements in 2012
in all areas of its core services: patient
care, education, and research.
Patient Care The majority of Vascular Surgery patient
services are provided at the Cardio-
vascular Center (CVC) located in Ann
Arbor, Michigan. We are happy to report
that 95 percent of polled CVC patients
said they would return for another visit.
Similar high ratings extend to our satellite
facility at the Livonia Vein Clinic (LVC),
where polled patients reported an overall
patient satisfaction rating of 96 percent.
Vascular Surgery has also met the UMHS
goal of seeing 80 percent of all new
patients within four weeks of their referral
date. Our vision is to create the best
patient care experience and provide the
most up-to-date and innovative vascular
care possible.
Education As a world-renowned academic center,
we are proud to have under our umbrella a
vascular surgery fellowship program, an
integrated vascular residency program,
and a research fellowship federally funded
by a National Institutes of Health (NIH)
sponsored T-32 training grant. In fact, we
will graduate the first of the original
integrated vascular residents in the
country. Our highly sought-after programs
continue to be competitive and attract the
best and brightest candidates. Our vision
is to continue to provide outstanding
clinical training for future academicians
and leaders in vascular surgery. In the
near future, our training program will be
increasingly competency-based with
simulation playing a more prominent
role.
Research In the areas of clinical and basic
science research, amidst a tentative
economy and uncertainty with federal
sponsors, Vascular Surgery managed to
maintain research operations within the
Conrad Jobst Vascular Research
Laboratories and at our Vascular
Mechanics Laboratory receiving awards
totaling more than $2.3M, which is on
par with the prior year total of $2.4M.
We were also able
to maintain
research spending
at our biomedical
clinics and
laboratories, as well
as with many
research
collaborators. Our
vision is to
improve the
human condition by discovery through
research on means to prevent, cure,
and lessen the burden of vascular
disease, and provide an arena to train
future vascular surgeons and scientists.
As we build on our solid foundation,
Vascular Surgery looks forward to
continued success and achievement.
Thomas Wakefield, MD
Section Head
V S ascular urgery
A section of the
Department of Surgery
Vascular Surgery Services As caregivers, our attention never diverts
from providing the best patient care
experience, which not only means achieving
the best possible surgical outcomes, but also
ensuring that the initial clinic visit and
subsequent follow-up are conducted with a
standard of excellence that represents the
Michigan Difference. We are happy to report
that during 2012, our clinic visits increased by
118 patients.
Since our move to the CVC in 2007, the
overall number of operative cases has
increased from 1,114 cases to 1,426 cases in
2012, representing a compounded annual
growth rate (CAGR) of 4.2 percent. With regard
to the patient experience, the University of
Michigan Health System measures patient
satisfaction via a patient survey with questions
evaluating a variety of categories. Survey
results in 2012 reflected the following
satisfaction ratings: scheduling (84 percent),
general customer service (91 percent), quality
of facility (89 percent), and pain management
(85 percent).
venous surgical procedures and outcomes are
presented below. In 2012, we began recording our
complications via the Vascular Inventory
Collaborative (VIC) Registry. Vascular and
Procedural
Indicators Target
Achievement
Level
Freedom From
Mortality 96% 97%
Freedom From
Myocardial In-
farctions 96% 97%
Freedom From
AAA (Abdominal
Aortic Aneurysm)
Open (Mortality) 96% 97%
Arterial Procedures Venous Procedures
Surgical Indicators
CVC Livonia Total
FY10: 7,268 3,162 10,430
FY11: 8,582 3,487 12,069
FY12: 8,761 3,426 12,187
0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
2007
1,114 Cases
2012
1,426 Cases
CAGR 4.2%
Vascular Operative Cases
Clinic Cases
Procedural
Indicators Target
Achievement
Level
Freedom From
Wounds 84-99% 97%
Freedom From
DVTs (Below The
Knee) 95-98% 97%
Freedom From
EHIT
(Endovenous
Heat Induced
Thrombus) 97% 97%
P A G E 2 2 0 1 2 V A S C U L A R S U R G E R Y
Diagnostic Vascular Unit The Diagnostic Vascular Unit (DVU)
underwent significant changes in 2012,
beginning with the addition of a third shift to
accommodate an increase in both patient
volume and requests for emergent studies. Our
full-service clinical diagnostic labs perform
approximately 2,100 tests every month, which
includes both inpatient and outpatient
procedures.
In addition, the DVU continued annual
screenings for both venous and arterial
disease. The venous screening, which tests for
deep vein thrombosis and venous insufficiency,
resulted in more than 100 new patients at both
the Livonia Vein Clinic (LVC) and the DVU.
Thirteen of these new patients resulted in
operative cases. The DVU and Peripheral Artery
Disease (PAD) program offered a joint
screening for peripheral arterial disease,
abdominal aortic aneurysm, and carotid
disease. Of the 86 patients seen, eight were
found to have disease.
These diagnostic
screenings provide us
with proactive measures
to help identify and treat
vascular diseases earlier
and with better results,
as well as provide
outreach services to the
community.
The DVU at the University Hospital,
Cardiovascular Center, Domino Farms, and
Briarwood received accreditation in venous,
arterial, and cerebrovascular testing by the
Intersocietal Accreditation Commission (IAC)
Vascular Testing. This is the first all four
locations have received this accreditation.
Meet Our Support Staff Our exemplary services could not have been provided had it not been for our top-quality clinic
and administrative staff.
“Our annual arterial and venous
screening events allow us to
reach out to the community,
raise awareness and establish
care for many vascular disease
processes that often go
undiagnosed.”
- Sandy Brown, MA, RDMS, RVT
Physician Assistants
David Allis, PA-C
Amy Ashlin-McSween, PA-C
Deborah Rutherford, PA-C
P A G E 3 2 0 1 2 V A S C U L A R S U R G E R Y
Left to right: Ann Luciano, NP; Raquel Clayton, RN; Becky Bertha, RN;
Dawn Skvarce; Clare Harris, NP; Sharon Landers; Michele Kantola, NP;
Susan Young, RN; Charlene Minard, RN; Elaine Fellows, NP; and
William Bill LaForge, RN.
Schedulers
Sharon Landers
Dawn Skvarce
OR Nursing Staff
Gloria McInturff, RN
Kelly Chiles, RN
Ann Flaton, RN
Jennifer Martz, CST
Cheryl Rutan, RN
Kate Tobiczyk, RN
Nurse Practitioners
Elaine Fellows, NP
Clare Harris, NP
Michele Kantola, NP
Ann Luciano, NP
Clinical Nurses
Becky Bertha, RN
Raquel Clayton, RN
Bill LaForge, RN
Charleen Minard, RN
Susan Young, RN
Administrative Staff
Greer Peters - Eshkanian
Sandra Martin
Pam Moss
Duwana Villemure
Multidisciplinary Aortic Program
experience with these children. The operative
management of children with complex arterial
disease now numbers more than 225. In the
past year, 23 pediatric-aged patients
underwent corrective vascular surgery. They
came from Western Europe, the Middle East,
and many major children’s hospitals in Canada
and across the United States.
The expert care of complex arterial diseases
in children is an essential part of the
University’s Vascular Surgery practice and has
been a visible contribution to the Michigan
Difference.
Clinical Trial (N-TA3CT) for the medical
management of small aneurysms. Seth Waits
entered the research laboratory as the
sponsored aortic
research fellow
studying failure
to rescue after
AAA repair.
Not only is the
MAP excelling in
patient care and
research, but
also in sponsoring a multidisciplinary case
conference. This continues to have broad
attendance and further contributes to
outstanding patient care.
P A G E 4
Since its embryonic origin nearly three
decades ago, the Pediatric Vascular Disease
Program at University of Michigan has become
the country’s most common destination for
children in need of surgical management of
occlusive or aneurysmal diseases of the
abdominal aorta and its branches. The
Program includes a multidisciplinary team led
by vascular surgeons Dawn Coleman, MD,
Jonathan Eliason, MD, and James Stanley, MD.
The team partners with physicians from the
specialties of interventional radiology, pediatric
nephrology, intensive care, and anesthesia, as
well as with nurses and social workers with
broad knowledge of this group of patients.
In 2006, the largest reported experience
with pediatric renovascular hypertension
caused by renal artery obstructions emanated
from this Program. Two years later, in 2008,
the world’s largest experience with childhood
abdominal aortic coarctation (narrowing) was
reported by this Program. In late spring 2013,
the Program’s activity with extremity arterial
reconstructions in preadolescent boys and girls
will be presented before the Society for
Vascular Surgery, and when published will
represent the world’s largest reported
Pediatric Vascular Disease Program
Vascular Surgery’s contribution to the
Cardiovascular Center’s Multidisciplinary Aortic
Program (MAP) continues to demonstrate
excellence in surgical outcomes for aortic
diseases. In 2012, 99 patients underwent
open or endovascular aneurysm repair for
complex abdominal aortic aneurysms. The 30-
day mortality for endovascular AAA repair was
1.4 percent, while the 30-day mortality for
open AAA repair was 3.0 percent.
In the area of aortic research, nine FDA-
regulated and two National Institutes of Health
(NIH)-sponsored trials, along with two
Department of Defense (DOD) contacts, were
awarded during the last two years. These
include the fenestrated endograft trial by Cook
Medical and the NIH-sponsored Non-Invasive
Treatment of Abdominal Aortic Aneurysm
2 0 1 2 V A S C U L A R S U R G E R Y
Left: Preoperative image of a young girl whose aorta was
absent with blood flow to her kidneys and lower extremi-
ties being supplied by multiple web-like collateral vessels.
Right: Postoperative image of newly constructed aorta
with branches to both kidneys and the vessels going to
her lower extremities.
Annual AAA Cases
2007 2008 2009 2010 2011 2012
110 98 115 100 97 99
85
90
95
100
105
110
115
120
Venous Health Program
Peripheral Arterial Disease Program
Innovative treatments include:
radiofrequency ablations/laser ablations for
superficial venous reflux,
phlebectomies using Trivex
technique (available in only
two other sites in Michigan
and only 150 sites
nationally) for the removal
of large and extensive
varicose veins,
pharmacomechanical
thrombolysis for aggressive iliofemoral venous
thrombosis, and recanalization of central veins
to treat significant chronic venous
insufficiency. The yearly volume of Venous
Health patients continues to rise.
The Venous Health Program is a
multidisciplinary, centralized, patient-centered
program that provides full service for the entire
spectrum of a patient’s venous disease. The
program features sub-specialty care,
establishing a uniform treatment approach.
Under the leadership of Clare Harris, NP, the
Venous Health Program involves
interdisciplinary faculty from Vascular Surgery,
Vascular Medicine, Interventional Radiology,
and the Livonia Vein Center.
P A G E 5
The Peripheral Arterial Disease (PAD)
program is a truly multidisciplinary program
with representatives from Vascular Surgery,
Interventional Radiology, Cardiology, and
Vascular Medicine. This is the only such
program in the country where cases are
discussed, optimal management strategies are
developed, and case management is shared
across these disciplines.
The program has a standardized outpatient
management approach, increased access to
wound care and pain management services,
and coordinated efforts that have resulted in
improvements in procedural complications and
guideline-recommended medical therapy. Due
to the dedication of our staff, under the
leadership of Ann Luciano, NP, patients and
referring physicians have utilized the program,
and percutaneous and surgical case volume of
all the participating disciplines have increased
significantly.
More specifically, the PAD clinic continues
to meet its goals of seeing new patients within
one week of referral. Free PAD screening in
September 2012 was a success and clinic
satisfaction scores are
greater than 90 percent.
The PAD program has
shared its care
protocols, including
statin use and hydration
practices, with other
disciplines within the
hospital. PAD program
staff have participated in site visits to other
hospital centers in
Southeastern
Michigan to share
their program
experiences. Quarterly
PAD morbidity and
mortality staff
meetings are held,
with all areas
conducting PAD procedures or caring for PAD
patients.
2 0 1 2 V A S C U L A R S U R G E R Y
Percent of Effort By Service
PAD Fiscal Year Stats
Note: NP: New Patient; RV: Returning Visit; H&P: Pre-
operative visit; POV: Post-operative visits.
Venous Health Program Fiscal Year Stats
34% 23%
43%
Cardiology
InterventionalRadiology
Vascular Surgery
17%45%
38%
Cardiology
InterventionalRadiology
Vascular Surgery
Percent of Effort By Service
The Veterans Administration (VA) hospital
remains a stalwart of clinical teaching for
residents and fellows. Vascular Surgery’s
effort is headed up by Peter Henke, MD,
Guillermo Escobar, MD, and Katherine
Gallagher, MD. Research activity is pending
Institutional Review Boards (IRB) and patient
safety information officer approval regarding
the Aastrom Stem Cell trial for PAD, for which
Peter Henke, MD is the local primary
investigator. Peter Henke, MD and John
Rectenwald, MD are also co-investigators at the
VA for the ATTRACT trial, a NIH-sponsored trial
evaluating the role of pharmacomechanical
thrombolysis versus best medical management
in iliofemoral DVT. In 2012, the VA Hospital’s
Vascular Surgery clinic treated 576 out-patients
and 101 in-patients. The Vascular Lab saw
2,781 out-patients and 817 in-patients.
Cardiovascular Center
The Livonia Vein Center (LVC) serves as an
initial triage for the University of Michigan
Venous Program and is an outpatient
procedural site.
Approximately 30
to 40 percent of
new patient
referrals to the
CVC’s Venous
Program come
from the LVC.
This past year,
the LVC in-
creased the total
number of new patients seen in a single year
and continues to pursue new marketing
events in an effort to reach all surrounding
communities. The LVC received the UMHS
Patient Satisfaction Award in spring and fall
2012 for overall patient satisfaction above
95 percent. This marks the third consecutive
year in which the LVC has achieved the
award. Lisa Pavone, MD, and Emily
Cummings, MD, both participated in the
Varisolve research study in 2012, giving
them the opportunity to learn foam
sclerotherapy. Future plans are to expand the
LVC into the Troy/Birmingham region in 2013
with a second location. The site would be
staffed with practitioners who currently
operate the LVC, including Lisa Pavone, MD,
and Emily Cummings, MD, as well as
incremental mid-level providers. A strategic
plan is currently under way, with a desire to
launch the second site as early as possible.
The expansion will increase demand for the
Venous Program at the CVC.
Veterans Administration
Livonia Vein Clinic
Vascular Surgery is an integral part of the
Cardiovascular Center, which includes 308
university physicians and scientists as active
CVC members. The CVC’s clinical and research
programs continued to grow in 2012. In
addition to the CVC’s unmatched facilities,
considerable funding for new ventures has
been available for years from a transformative
gift from the family of Samuel and Jean
Frankel. In 2012, discussions commenced
regarding a public celebration of their
$50,000,000 largesse and the opportunity to
name the CVC after this generous family.
Vascular Surgery is proud to be part of what in
future years will be known as the University of
Michigan Samuel and Jean Frankel
Cardiovascular Center.
2 0 1 2 V A S C U L A R S U R G E R Y P A G E 6
P A G E 7
Our student mentoring program is a
tangible and visible sign of our absolute
commitment to the future of Vascular Surgery.
Thirty-five M3 students rotated into
Vascular Surgery for the 2011-2012 Clerkship
Residency and Fellowship Programs
Other Programs
American Board of Surgery’s qualifying and
certifying examinations. We are proud to
announce that our first integrated vascular
resident, Frank Vandy, MD, will graduate in
June 2013.
year. This program continues to stimulate
student interest in Vascular Surgery. Two
University of Michigan students have matched
into Vascular residency programs, and one into
our integrated Vascular residency program.
Students
In addition to scholarly instruction, Vascular
Surgery sponsored the Milton E. Bryant lecture
in 2012. The distinguished Robert M. Zwolak,
MD, Professor of Surgery, Dartmouth Medical
School, presented “The Patient-Centered Out-
comes Research Institute: Legislation, Roll-out,
Impact.” In partnership with the Conrad Jobst
Vascular Institute in Toledo, Vascular Surgery
co-sponsored the annual Conrad Jobst Lecture,
which featured a keynote address by Gregory
L. Moneta, MD. His discussion, titled “The Ve-
nous Wars…Wins…Losses…Ties,” was a rous-
ing event that sparked tremendous debate sur-
rounding the ethics and decisions of using clin-
ical trials for the treatment of illness.
Vascular Surgery Residents and Fellows. Front Row (left to right):
J. Rectenwald, MD (Program Director); S. Arya, MD (Fellow); F.
Vandy, MD (Chief Resident); T. Wakefield, MD (Section Head).
Back Row (left to right): N. Osborne, MD (Fellow); T. Chen, MD
(Year 2 Resident); D. Campbell, MD (Year 3 Resident); D. Horne,
MD (Year 1 Resident); and J. Knepper, MD (Year 4 Resident).
NIH-sponsored T-32 Training Grant Fellows. Left to right:
T. Shih, MD; A. Obi, MD; M. Girotti, MD; A. Gonzalez, MD.
2 0 1 2 V A S C U L A R S U R G E R Y
Vascular Surgery’s training programs
continue to be among the most sought-
after programs in the nation, enabling us
to match highly competitive trainees to our
programs. Our residents and fellows
continue to excel on their VSITE, SPE, and
Greenfield Award
June 6, 2013
Conrad Jobst Annual Lecture
September 19-20, 2013
Bryant Lecture
April 11-12, 2013
P A G E 8
Vascular Surgery Research Vascular Surgery Research had a strong
year, with significant research endeavors and
scholarly pursuits. Examples of Vascular
Surgery funding opportunities include:
Guillermo Escobar’s, MD, CVC McKay
Research Grant to evaluate the effects of
iodinated contrast dye in a rodent model, as
well as in humans. Jose Diaz, MD, was
awarded a CVC McKay Research Grant to
study the effect of rosuvastatin in deep vein
thrombosis. He also obtained funding from
ATP Therapeutics to evaluate the
antithrombotic efficacy of APT 402 in a venous
thrombosis model. Katherine Gallagher, MD,
secured funding as a recipient of the Taubman
Scholar Award as well as the Wylie Research
Award.
Scholarly activity within Vascular Surgery
Research was outstanding, with 94 peer-
reviewed publications, 29 presentations at
international, national, and regional
conferences, and 22 book chapters written by
members.
Conrad Jobst Vascular Research Laboratories April 2012 brought much-needed changes
to the Conrad Jobst Vascular Research
Laboratories at the University of Michigan. The
entire Conrad Jobst Vascular Research
Laboratory complex, consisting of seven
separate but integrated units, was moved
from its original location in the Medical
Science Research Building II (MSRB) to the
new North
Campus
Research
Complex
(NCRC). The
move was
under the
direction of
Daniel Myers,
DVM, the head
of the Conrad
Jobst Vascular
Research Laboratories. This consolidation has
allowed the researchers an opportunity to
better collaborate on studies and to share
resources, thus containing costs.
Positive changes in the Conrad Jobst
Vascular Research Laboratories have been
noticed by potential donors visiting the new
location. These updated and expanded
facilities were instrumental in obtaining two
DOD grants as well as the $411,000 Bristol
Myers Squibb grant. Like labs across the
country, the Conrad Jobst Vascular Research
Laboratories will be challenged to obtain
funding during 2013. The laboratories currently
have five national funded government grants,
along with one NIH-sponsored T-32 training
grant.
Aortic Modeling The Vascular Mechanics Laboratory was
moved to new quarters at the NCRC where the
bench-top and computer models for the
experimental study of aortic dissection are
assembled. The laboratory, under the direction
of Ramon Berguer, MD, PhD, is working in
collaboration with Juan Parodi, MD, the
2 0 1 2 V A S C U L A R S U R G E R Y
Left: A mathematical model showing the blood flow in
the distal part of an aortic dissection. Right: A model of
the aorta constructed in a 3D printer.
surgeon responsible for developing the first
endograft to treat aortic aneurysms. The
current work is dedicated to modeling and
providing the mechanical effects of a new
approach (septectomy) to treat acute aortic
dissection.
Through a recently endowed Diethrich
Professorship in Engineering and Vascular
Surgery we have recruited Alberto Figueroa,
PhD, who previously worked at Stanford
developing a successful 3D functional and
anatomical imaging map that can be
generated through computerized
angiographic tomography. Alberto Figueroa,
PhD, is currently the head of Biomedical
Engineering at King’s College in London, UK.
Clinical Trials In 2012, the ongoing challenge of obtaining
IRB approval for retrospective studies was
addressed. With the introduction of new
eRsearch capabilities, these retrospective
studies have been re-assembled into exempt
studies, enabling separate and specific
studies to be combined into larger, more open
exempt studies.
This reduces IRB
approval time while
maintaining the
highest compliancy
standards, and
allows clinicians,
residents, and
fellows a much
faster approval time
for their
retrospective
studies. In 2012,
In October 2007, a quality improvement
registry funded by Blue Cross Blue Shield of
Michigan was initiated. This multi-center,
multi-disciplinary outcome registry — the first
of its kind in the United States — was
designed to improve quality of care and
outcomes. In January 2012, the BMC2
Vascular Interventional Collaborative (VIC )
program started to include open vascular
procedures. The collaborative is led by Peter
Henke, MD, for open surgical cases and
Michael Grossman, MD, for PVI. Quarterly
reports are given to individual physicians,
along with departmental reports indicating
outcomes for surgical procedures. Outcomes
include death, infections, amputations,
myocardial infarctions, and strokes. In the
future, we will be participating in selecting
Quality Assurance
161 patients were enrolled in our clinical
studies from the several hundred that were
screened.
In addition to retrospective studies,
researchers from Vascular Surgery have been
pioneers in the use of alternative contrast
agents such as carbon dioxide (CO2) gas for
safe endovascular aneurysm repair (EVAR) in
patients with impaired kidney function. Well
over 100 patients have had EVAR performed
for AAA using CO2 as a contrast media. Data
suggest it is both technically feasible and safe
to use. Enrique Criado, MD, has performed
more than 150 endovascular aneurysm repairs
using CO2 angiography instead of nephrotoxic,
conventional iodinated contrast angiography.
John Rectenwald, MD, is a primary site
investigator for the National Zenith
Fenestrated Aortic Aneurysm trial. He is also a
local co-investigator with Jonathan Eliason,
MD, on the Noninvasive Treatment of AAA
Intact, a NIH-sponsored multicenter trial.
M2S modules as well. Currently, our venous
data is being entered
into a RedCap database,
and outcomes from that
database are reported to
the CVC dashboard along
with the open surgical
outcomes of arterial
procedures. We will be
partnering with leaders
in the next M2S varicose
vein registry.
P A G E 9 2 0 1 2 V A S C U L A R S U R G E R Y
Left to right: Susan Blackburn, RN,
MBA (Clinical Trial/Research); and
Cathy Stabler, RN, BSN (Quality
Assurance).
CO2 aortography during place-
ment of an endograft for aortic
aneurysm repair.
Faculty Updates
Ramon Berguer, MD
Continues as Editor, Annals of Vascular Surgery (Ann Arbor), and Annales de Chirurgie Vascu-
laire (Paris), and Annales de Cirugia Vascular (Barcelona)
Stopped his clinical practice December 31, 2012, but continues with his strong research ef-
forts
Enrique Criado, MD
Named the inaugural John R. Pfeifer Professor of Vascular Surgery
Dawn Coleman, MD
Started as Assistant Professor in Vascular Surgery at University of Michigan
Emily Cummings, MD
Became a Registered Vascular Technologist through the American Registry for Medical Diag-
nostic Sonography
Serves as a member of the American Venous Forum Ulcer Committee and part of the Venous
Ulcer Guidelines Taskforce
Jose Diaz, MD
Awarded Young Investigator Award at AAA Epidemiology, Genetics, & Pathophysiology Confer-
ence in Danville, PA (co-author, national meeting)
Served as Course Director for international course: Basic Science in DVT. III World Symposi-
um of Advances in Phlebology and Lymphology, BA, Argentina
Vascular Surgery Faculty. Front Row (left to right): R. Berguer, MD; T. Wakefield, MD; J. Stanley, MD; Back Row (left
to right): J. Diaz, MD; J. Rectenwald, MD; E. Cummings, MD; D. Coleman, MD; J. Eliason, MD; P. Henke, MD;
D. Myers, DVM MPH; K. Gallagher, MD; L. Pavone, MD; G. Escobar, MD; and E. Criado, MD.
P A G E 1 0 2 0 1 2 V A S C U L A R S U R G E R Y
Jonathan Eliason, MD
Named the second S. Martin Lindenauer Professor of Vascular Surgery
Received a prestigious Department of Defense grant for his work on the treatment of acute
aortic injury in the field
Serves as Chair of the Membership Committee for the Midwestern Vascular Surgical Society
Guillermo Escobar, MD
Awarded the Arnold G. Coran Award for Excellence in Surgical Teaching
Awarded the Peripheral Vascular Surgery Society Research Grant
Awarded the University of Michigan Cardiovascular Center McKay Research Award
Selected for the Young Surgeons Advisory Committee for the Society of Vascular Surgery
Katherine Gallagher, MD
Awarded the American Heart Association Young Investigator Award, Michigan Chapter
Awarded the Wylie Scholar in Academic Vascular Surgery Award
Received Society for Vascular Surgery Woman’s Leadership Grant
Awarded the University of Michigan Taubman Emerging Scholar Grant and McKay Heart of a
Champion Award
Peter Henke, MD
Named President, American Venous Forum
Serves as Associate Editor of the Research Section of the Journal of Vascular Surgery.
Named President, Michigan Vascular Society
Daniel Myers, DVM
Received American Society of Laboratory Animal Practitioners Excellence in Research Award
Became member of the Frederick A. Coller Surgical Society (first veterinarian to be inducted)
Received 2011 University of Michigan Endowment for Basic Sciences Teaching Award
Lisa Pavone, MD
Appointed to the American College of Phlebology Board
John Rectenwald, MD
Serves as member of the Society for Vascular Surgery Clinical Practice Council
Serves as Chairman, Society for Vascular Surgery Resident & Student Outreach Committee
Serves as member in the Association of Program Directors in Vascular Surgery, Education
Committee
James Stanley, MD
Established the Stanley Professorship in Vascular Surgery
Received the Founder’s Award from the Fibromuscular Dysplasia Society of America
Received the Lifetime Achievement Award, Society for Vascular Surgery
Continues as the Senior Associate Director Medical Arts Program, University of Michigan
Medical School
Thomas Wakefield, MD
Named the inaugural James C. Stanley Professor of Vascular Surgery
Received the 2012 Venous Research Award from the Venous Disease Coalition
Named the University of Toledo School of Medicine Alumnus of the Year
P A G E 1 1 2 0 1 2 V A S C U L A R S U R G E R Y
Development
P A G E 1 2
University of Michigan Vascular Surgery
is pleased to provide you with an annual
update on our successes. Many of these
would not have been possible without our
generous supporters. Please help us realize
Your Support Makes a Difference
Thanks to philanthropic support from
the Jobst and Frankel Foundations, a
tremendous amount of knowledge has
originated from the two laboratories
carrying their names. Also, during the
2012 academic year, Edward (Ted)
Diethrich, a University of Michigan
undergraduate and medical student
alumnus, established a new faculty
position — a Professorship in Biomedical
Engineering in Vascular Surgery — which
will carry his name. Last but not least,
our research is enriched by a generous
gift from the Biardi family and Bud
Stoddard.
Vascular Surgery at Michigan
continues to make a difference, thanks
to our charitable philanthropic
contributors. We are exceedingly grateful
to all those who have helped us maintain
our solid commitment to understanding,
presenting, and treating vascular
disease.
Vascular Surgery is committed to the
betterment of humankind, which is made
possible through ongoing philanthropic
support. Our Doan, Frankel, Handleman,
Lindenauer, Pfeifer, and Stanley
Professorships, for example, set us apart
from our peers. Endowed by generous
patients, friends, and alumni who value the
life-changing accomplishments of academic
vascular surgeons, our Professorships
provide resources and time for their holders
to pursue new and often unchartered
opportunities to advance medicine.
Our educational programs receive
ongoing support from the Bryant-Arnold,
DeWeese, Greenfield, and Lindenauer
funds, each established to benefit our
trainees. Additional endowments enrich our
community with the annual Jobst and
Bryant lectures and the Berguer Lecture on
Ethics, a generous donation made this year.
University of Michigan Cardiovascular Center,
1500 E. Medical Center Dr.
Ann Arbor, MI 48109-5867
Phone: 734.936.5820
2 0 1 2 V A S C U L A R S U R G E R Y
Special thanks goes to Michael
Mulholland, MD, Department of Surgery;
Kim Eagle, MD; David Pinsky, MD; Richard
Prager, MD; James Stanley, MD; and Linda
Larin, Chief Administrative Officer, CVC for
their ongoing support.
Acknowledging Our Supporters
future successes by donating to Vascular
Surgery. Donations may be made by call-
ing (734) 232-6017 or online at
www.giving.umich.edu/give/surgery-
vascular.